We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Test Uses Tiny Worms to Detect Early Signs of Cancer

By LabMedica International staff writers
Posted on 24 Nov 2021

Scientists have developed a screening test that uses tiny worms to detect early signs of cancer in urine that could help boost routine screening. More...

Scientists at Hirotsu Bio Science (Tokyo, Japan) have developed N-NOSE, a cancer screening test that uses highly sensitive olfactory sensory functions of genetically modified a type of worm called "C. elegans" (nematodes) with an acute sense of smell. N-NOSE, which stands for Nematode Nose, uses the chemotaxis characteristic of nematodes, i.e., attractive responses to an odor it likes and repulsive responses to an odor it does not like, as an indicator. Nematodes are known to respond to 15 types of cancer of the stomach, colorectal, lung, breast, pancreatic, liver, prostate, uterine, esophageal, gall bladder, bile duct, kidney, bladder, ovarian, and oral/pharyngeal.

C. elegans nematode is the first multicellular organism to have its entire genome sequenced and is a very popular model organism in biological research. The idea of using nematodes, live creatures, in cancer testing stems from the fact that they have superior olfactory sensors that no man-made device can come close to. Because it has no eyes or ears, it relies on smell to navigate its environment and detect food. C. elegans therefore has a well-developed sense of smell and about 1,200 types of olfactory receptor genes that are able to detect minute odors that machines cannot detect. The novel N-NOSE test that employs the worm’s natural capabilities is not invasive, causes no pain and can be used for early detection of cancer.

The test requires a small amount of urine and is inexpensive since nematodes are inexpensive to breed. Each nematode lays as many as 300 eggs and feeds on coliform bacterium E. coli, making it inexpensive to breed C. elegans populations. Currently available cancer diagnostic tests often do not detect incipient cancer and it has been thought very difficult to know the existence of cancer at an early stage. However, nematodes respond to the minute odor of cancer, which is undetectable with existing tests, and thus make it possible to predict risks. Early detection of cancers as early as Stages 0 and 1 is possible with N-NOSE according to clinical studies, and one test is able to detect cancers regardless of their locations. The simple, painless urine test is suitable as a cancer test for all generations, including children. The company believes that in future, children will take regular cancer screening tests to detect pre-symptomatic tumors.

Related Links:
Hirotsu Bio Science 


New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Collection and Transport System
PurSafe Plus®
Laboratory Software
ArtelWare
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.